Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Sarcoma 7Leiomyosarcoma 3Sarcoma, Synovial 2Sarcoma, Alveolar Soft Part 2Ovarian Neoplasms 2Neurofibrosarcoma 2Malignant mesenchymal tumor 2Liposarcoma 2Histiocytoma, Malignant Fibrous 2Hemangiosarcoma 2Hemangiopericytoma, Malignant 2Fibrosarcoma 2Unspecified Childhood Solid Tumor, Protocol Specific 1Unspecified Adult Solid Tumor, Protocol Specific 1Solitary Fibrous Tumors 1Soft Tissue Neoplasms 1Sarcoma, Ewing 1Sarcoma, Endometrial Stromal 1Rhabdomyosarcoma 1Recurrent High Grade Meningioma 1Neuroectodermal Tumors, Primitive, Peripheral 1Neoplasm Metastasis 1Ichthyosis, X-Linked 1Gastrointestinal Stromal Tumors 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1Desmoplastic Small Round Cell Tumor 1Chondrosarcoma, Mesenchymal 1Chondrosarcoma, Extraskeletal Myxoid 1Central Nervous System Neoplasms 1

Interventions

Irinotecan 2Vincristine 1Trabectedin 1Pemetrexed 1Early Intervention, Educational 1Absorptiometry, Photon 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Unspecified Childhood Solid Tumor, Protocol Specific × Trabectedin × Clear all
NCT00006463 2014-02-21

Ecteinascidin 743 in Treating Children With Refractory Solid Tumors

Children's Oncology Group

Phase 1 Completed
13 enrolled
Other solid neoplasm

Unspecified Childhood Solid Tumor, Protocol Specific

Data powered by HemOnc (CC BY 4.0) Colophon âš¡